KEGG   DRUG: Indacaterol acetate, glycopyrronium bromide and mometasone furoate
Entry
D11861            Mixture   Drug                                   
Name
Indacaterol acetate, glycopyrronium bromide and mometasone furoate;
Enerzair (TN)
Component
Indacaterol acetate [DR:D11009], Glycopyrrolate [DR:D00540], Mometasone furoate [DR:D00690]
Remark
Therapeutic category: 2290
ATC code: R03AL12
Product: D11861<JP>
Efficacy
Antiasthmatic
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 R RESPIRATORY SYSTEM
  R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
   R03A ADRENERGICS, INHALANTS
    R03AL Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
     R03AL12 Indacaterol, glycopyrronium bromide and mometasone
      D11861  Indacaterol acetate, glycopyrronium bromide and mometasone furoate <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  22  Respiratory organ agents
   229  Miscellaneous
    2290  Miscellaneous
     D11861  Indacaterol acetate, glycopyrronium bromide and mometasone furoate
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11861
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D11861
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system